Organizations
Conferences
Info & Opinion
October 7, 2008
ACS talks about a new product. The company is betting the combination of EDC and CTMS will appeal to biotech firms and contract research organizations.
Bayer’s Rob Musterer discusses why current clinical trial management systems aren’t serving the industry.
With impressive numbers, Pfizer’s Mike Collins talked about how the company is streamlining its clinical trial process.
In the third part of our series, a softer approach to win the hearts of clinician-investigators.
In the second segment of our series on investigator relationship management, Lilly discusses plans to zero in on high-performing sites.
Perceptive Informatics announced a new version of its Interactive Web Response System (IWRS). Perceptive’s IWRS 2.0 integrates with its industry leading Interactive Voice Response System (IVRS) and is a sophisticated web interface for data capture, patient randomization and the management of study drug inventory for clinical trials. “Perceptive started offering… more...
Advanced Clinical Software signed a deal with the Gelsinger Health System of central and northeastern Pennsylvania. ACS said Study Manager, its clinical trial management system (CTMS), will be rolled out in stages. Geisinger decided that it needed an efficient, standardized methodology for managing clinical trials across multiple therapeutic areas. Gelsinger… more...
DataLabs has incorporated Site Manager as an integrated addition to the company’s software platform. DataLabs’ Site Manager is advanced clinical trial management (CTM) software that enables collaborative processes to quickly identify, select and initiate investigator sites. It allows easy monitoring, administration and communication with sites. Site Manager was originally developed… more...
IBM, Averion and Winchester Business Systems have been doing collaborative seminars linking the technologies of all three companies. As Winchester noted in a release about a recent seminar in the Boston area: “The current systems used by most organizations--individual spreadsheets and disconnected databases--cannot support the increased volume and complexity of… more...
Parexel International announced second-quarter results for the period ending December 31, 2005. Consolidated service revenue increased 10.3% to $149.8 million, compared with $135.8 million in the prior period. Operating income was $10.6 million, versus $7.5 million in the comparable quarter of the prior year. The breakdown by business segment: $108.9… more...